Glycogen storage disease type I surgery: Difference between revisions
Jump to navigation
Jump to search
| Line 13: | Line 13: | ||
==Surgery== | ==Surgery== | ||
*Liver transplantation may improve the survival of patients with glycogen storage disease type 1. | *Liver transplantation may improve the survival of patients with glycogen storage disease type 1. | ||
*Survival rates of patients after liver transplantation are: | *Survival rates of patients after liver transplantation are:<ref name="pmid22066793">{{cite journal| author=Maheshwari A, Rankin R, Segev DL, Thuluvath PJ| title=Outcomes of liver transplantation for glycogen storage disease: a matched-control study and a review of literature. | journal=Clin Transplant | year= 2012 | volume= 26 | issue= 3 | pages= 432-6 | pmid=22066793 | doi=10.1111/j.1399-0012.2011.01549.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22066793 }} </ref> | ||
** 1 year survival rate of 82% | |||
** 5 year survival rate of 76% | |||
** 10 year survival rate of 64% | |||
==References== | ==References== | ||
Revision as of 21:31, 8 November 2017
|
Glycogen storage disease type I Microchapters |
|
Differentiating Glycogen storage disease type I from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Glycogen storage disease type I surgery On the Web |
|
American Roentgen Ray Society Images of Glycogen storage disease type I surgery |
|
Directions to Hospitals Treating Glycogen storage disease type I |
|
Risk calculators and risk factors for Glycogen storage disease type I surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Liver transplantation is the final treatment for patients with metabolic disease associated associated with GSD type 1.
Indications
Indications for liver transplantation include:[1]
- Patients with multifocal
- Growing lesions that do not regress with improved dietary regimens
- Patients who do not have evidence of distant metastatic disease.
Surgery
- Liver transplantation may improve the survival of patients with glycogen storage disease type 1.
- Survival rates of patients after liver transplantation are:[2]
- 1 year survival rate of 82%
- 5 year survival rate of 76%
- 10 year survival rate of 64%
References
- ↑ Kishnani, Priya S.; Austin, Stephanie L.; Abdenur, Jose E.; Arn, Pamela; Bali, Deeksha S.; Boney, Anne; Chung, Wendy K.; Dagli, Aditi I.; Dale, David; Koeberl, Dwight; Somers, Michael J.; Burns Wechsler, Stephanie; Weinstein, David A.; Wolfsdorf, Joseph I.; Watson, Michael S. (2014). "Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics". Genetics in Medicine. doi:10.1038/gim.2014.128. ISSN 1098-3600.
- ↑ Maheshwari A, Rankin R, Segev DL, Thuluvath PJ (2012). "Outcomes of liver transplantation for glycogen storage disease: a matched-control study and a review of literature". Clin Transplant. 26 (3): 432–6. doi:10.1111/j.1399-0012.2011.01549.x. PMID 22066793.